₹0 0
₹0 0
Nextgen Biotech

Call us:

menu

Myzomib 2mg - Bortezomib Injection

  • Home
  • Myzomib 2mg - Bortezomib Injection

Myzomib 2mg - Bortezomib Injection

Myzomib 2mg Injection contains Bortezomib, a proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma (MCL). It works by blocking the proteasome system in cancer cells, leading to their destruction and reducing tumor progression.

  • ₹2200

Choose Quantity:

-
+
+ Add To Cart
Add to wishlist
Share
Description Product Details
General Information:
Generic Name: Bortezomib
Brand Name: Myzomib
Packing: Single-use vial
Strength: 2mg
Company: Mylan Pharmaceuticals Pvt. Ltd.
Form: Lyophilized Powder for Injection
Category: Proteasome Inhibitor, Anti-Cancer Drug
Product Introduction:
Myzomib 2mg Injection is an anti-cancer drug used in chemotherapy. It belongs to the proteasome inhibitor class and is commonly prescribed for treating multiple myeloma and mantle cell lymphoma. It works by preventing cancer cells from breaking down proteins, leading to their death.
Uses of Myzomib 2mg
Myzomib 2mg is prescribed for the treatment of:
  1. Multiple Myeloma – A cancer affecting plasma cells in the bone marrow.
  2. Mantle Cell Lymphoma (MCL) – A rare and aggressive type of non-Hodgkin’s lymphoma.
  3. Waldenström’s Macroglobulinemia (Off-label Use) – A slow-growing type of lymphoma.
  4. Light Chain Amyloidosis (Off-label Use) – A condition where abnormal proteins accumulate in organs.
  5. Other Hematological Malignancies (Experimental Uses).
How Myzomib 2mg Works (Mechanism of Action):
  1. Bortezomib inhibits the 26S proteasome, an enzyme responsible for breaking down proteins inside cancer cells.
  2. Blocking this process causes toxic proteins to accumulate, leading to cellular stress and apoptosis (programmed cell death).
  3. This disruption halts tumor growth and slows down cancer progression.
Dosage of Myzomib 2mg
Typical Recommended Dose:
  1. For Multiple Myeloma & Mantle Cell Lymphoma:
    1. 1.3 mg/m² body surface area administered twice weekly on Days 1, 4, 8, and 11, followed by a 10-day rest period.
    2. Treatment cycles last 3 to 4 weeks and may continue based on patient response.
📌 Dose adjustments may be required in case of liver disease or severe side effects.
Method of Administration (How to Take It)
  1. Administered as an intravenous (IV) or subcutaneous (SC) injection.
  2. Given under medical supervision only.
  3. IV infusion: Injected over 3-5 seconds into a vein.
  4. Subcutaneous injection: Preferred method to reduce nerve damage.
  5. Not for self-administration.
Side Effects of Myzomib 2mg
Common Side Effects:
  1. Fatigue and weakness
  2. Nausea and vomiting
  3. Diarrhea or constipation
  4. Fever
  5. Low blood cell counts (anemia, neutropenia)
  6. Peripheral neuropathy (tingling/numbness in hands or feet)
Severe Side Effects (Seek Immediate Medical Help):
  1. Severe allergic reactions – Rash, swelling, breathing difficulty.
  2. Liver toxicity – Yellowing of skin/eyes.
  3. Heart problems – Irregular heartbeat, heart failure.
  4. Severe infections – Pneumonia, sepsis.
  5. Tumor lysis syndrome (TLS) – Kidney failure due to rapid cancer cell breakdown.
⚠️ Peripheral neuropathy is a frequent side effect. Patients should report any numbness, pain, or tingling.
Precautions Before Taking Myzomib 2mg
  1. Pregnant & Breastfeeding Women: Avoid use due to fetal harm.
  2. Liver or Kidney Disease: May require dose modifications.
  3. Heart Conditions: Increased risk of heart failure and arrhythmias.
  4. Low Blood Cell Counts: Monitor for infections and bleeding risks.
  5. Peripheral Neuropathy: Use with caution if there is a history of nerve damage.
Drug Interactions (Medications That May Interact)
Myzomib 2mg may interact with:
  1. CYP3A4 inhibitors (Ketoconazole, Ritonavir): May increase toxicity.
  2. CYP3A4 inducers (Rifampin, Carbamazepine): May reduce effectiveness.
  3. Antihypertensive drugs: Can cause low blood pressure.
  4. Diabetes medications: May require blood sugar monitoring.
  5. Warfarin & Blood Thinners: Increases the risk of bleeding.
⚠️ Always inform your doctor about all current medications before starting Myzomib.
Allergy Warnings
  1. Do not use if allergic to Bortezomib, boron, or mannitol.
  2. Signs of an allergic reaction:
    1. Rash, itching, swelling
    2. Difficulty breathing
    3. Severe dizziness
🚨 Seek emergency medical attention if allergic symptoms occur.
Storage Instructions
  1. Store at 2°C - 8°C (refrigerated).
  2. Keep in original packaging away from light.
  3. Do not freeze.
  4. Use reconstituted solution within the recommended time frame.
Overdose Information
Symptoms of Overdose:
  1. Severe low blood pressure
  2. Loss of consciousness
  3. Increased risk of infections
  4. Severe nerve damage
What to Do in Case of Overdose?
  1. Seek immediate medical attention.
  2. Hospitalization and supportive care required.
Missed Dose Instructions
  1. If a dose is missed, contact your doctor immediately.
  2. Do not double the dose to make up for a missed one.
  3. Delays in dosing may require treatment adjustments.

In The Same Category

Cart